Zobrazeno 1 - 10
of 51
pro vyhledávání: '"C L, Willman"'
Autor:
John C. Reed, Elizabeth A. Raetz, Mary V. Relling, Stella Davies, Dong Joon Min, Deepa Bhojwani, William L. Carroll, James R. Downing, C. L. Willman
Publikováno v:
Hematology. 2003:102-131
The outcome for children with acute lymphoblastic leukemia (ALL) has improved dramatically with current therapy resulting in an event free survival exceeding 75% for most patients. However significant challenges remain including developing better met
Publikováno v:
Hematology. 2000:110-132
The myelodysplastic syndromes (MDS) constitute a challenge for the biologist as well as for the treating physician. In Section I, Dr. Willman reviews the current classifications and disease mechanisms involved in this heterogeneous clonal hematopoiet
Autor:
Marilyn L. Slovak, C. Rankin, Pu Paul Liu, David S. Viswanatha, David R. Head, C. L. Willman, I-Ming Chen
Publikováno v:
Blood. 91:1882-1890
The inv(16)(p13q22) and t(16;16)(p13;q22) cytogenetic abnormalities occur commonly in acute myeloid leukemia (AML), typically associated with French-American-British (FAB) AML-M4Eo subtype. Reverse transcriptase-polymerase chain reaction (RT-PCR) tec
Autor:
Andrew J. Carroll, David R. Head, P. Erickson, James R. Downing, Susana C. Raimondi, A. M. Curcio-Brint, Karl S. Theil, Curt I. Civin, T. A. Motroni, M. G. Hulshof, Harry A. Drabkin, C. L. Willman
Publikováno v:
Blood. 81:2860-2865
The 8;21 translocation is one of the most common chromosomal translocations in acute myelogenous leukemia (AML), accounting for 40% of pediatric AML with French-American-British (FAB)-M2 morphology. The chromosomal breakpoints have recently been iden
Publikováno v:
Blood. 79:2399-2403
Because neither morphologic nor routine cytochemical features are pathognomonic, the diagnosis of acute megakaryoblastic leukemia (AML- M7) is difficult, requiring either specialized ultrastructural or immunologic techniques. Because the ultrastructu
Autor:
Holly Gundacker, Soheil Meshinchi, Yaddanapudi Ravindranath, Richard A. Larson, Marilyn L. Slovak, John M. Bennett, Susana C. Raimondi, Clara D. Bloomfield, Todd A. Alonzo, Derek L. Stirewalt, C. L. Willman, Nyla A. Heerema, Gordon W. Dewald, Martin S. Tallman, F R Appelbaum, Andrew J. Carroll
Publikováno v:
Leukemia. 20(7)
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies
Autor:
F F, Zhang, J L, Murata-Collins, P, Gaytan, S J, Forman, K J, Kopecky, C L, Willman, F R, Appelbaum, M L, Slovak
Publikováno v:
Genes, chromosomescancer. 28(3)
Multicolor spectral karyotyping allows simultaneous visualization of all human chromosomes and screening for chromosomal rearrangements without a priori knowledge of any abnormalities involved. Based on this potentially increased sensitivity, we inve
Autor:
C, Crump, C, Chen, F R, Appelbaum, K J, Kopecky, S M, Schwartz, C L, Willman, M L, Slovak, N S, Weiss
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(5)
Individuals with a homozygous deletion of the glutathione S-transferase theta 1 (GSTT1) gene lack GSTT1 enzymatic detoxification of environmental carcinogens by conjugation with glutathione. The GSTT1 gene deletion has been associated with carcinogen
Publikováno v:
Hematology/oncology clinics of North America. 14(1)
Effective treatment of the elderly patient with AML remains a challenging task. Acute myelogenous leukemia is clearly a different disease in the elderly than in the young, for many reasons, both clinical and biologic, which contribute to the worse pr
Autor:
C L, Willman
Publikováno v:
Seminars in hematology. 36(4)
Traditionally, acute myeloid leukemia (AML) has been diagnosed and classified based on the morphologic and cytochemical criteria of the French-American-British (FAB) classification system. However, more recent studies have demonstrated that the cytog